- Home
- ABOS vs JYNT Comparison
ABOS vs JYNT Comparison
Compare ABOS & JYNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABOS
- JYNT
- Stock Information
- Founded
- ABOS 1996
- JYNT 2010
- Country
- ABOS United States
- JYNT United States
- Employees
- ABOS N/A
- JYNT N/A
- Industry
- ABOS Biotechnology: Pharmaceutical Preparations
- JYNT Multi-Sector Companies
- Sector
- ABOS Health Care
- JYNT Miscellaneous
- Exchange
- ABOS Nasdaq
- JYNT Nasdaq
- Market Cap
- ABOS 99.1M
- JYNT 154.2M
- IPO Year
- ABOS 2021
- JYNT 2014
- Fundamental
- Price
- ABOS $1.56
- JYNT $10.22
- Analyst Decision
- ABOS Strong Buy
- JYNT Strong Buy
- Analyst Count
- ABOS 3
- JYNT 2
- Target Price
- ABOS $9.33
- JYNT $17.50
- AVG Volume (30 Days)
- ABOS 379.4K
- JYNT 50.4K
- Earning Date
- ABOS 11-12-2024
- JYNT 03-06-2025
- Dividend Yield
- ABOS N/A
- JYNT N/A
- EPS Growth
- ABOS N/A
- JYNT N/A
- EPS
- ABOS N/A
- JYNT N/A
- Revenue
- ABOS N/A
- JYNT $120,795,620.00
- Revenue This Year
- ABOS N/A
- JYNT $3.28
- Revenue Next Year
- ABOS N/A
- JYNT N/A
- P/E Ratio
- ABOS N/A
- JYNT N/A
- Revenue Growth
- ABOS N/A
- JYNT 5.26
- 52 Week Low
- ABOS $1.54
- JYNT $8.94
- 52 Week High
- ABOS $5.09
- JYNT $17.82
- Technical
- Relative Strength Index (RSI)
- ABOS 30.29
- JYNT 42.53
- Support Level
- ABOS $1.69
- JYNT $9.98
- Resistance Level
- ABOS $1.88
- JYNT $10.81
- Average True Range (ATR)
- ABOS 0.13
- JYNT 0.43
- MACD
- ABOS -0.00
- JYNT 0.02
- Stochastic Oscillator
- ABOS 4.88
- JYNT 50.00
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.
About JYNT The Joint Corp.
The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has two operating business segments; the Corporate Clinics segment is comprised of the operating activities of the company-owned or managed clinics, and The Franchise Operations segment is comprised of the operating activities of the franchise business unit. The company generates maximum revenue from the Corporate clinic's segment.